Dow Down0.33% Nasdaq Down1.07%

Endocyte, Inc. (ECYT)

-NasdaqGS
7.00 Down 0.26(3.64%) 10:50AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 64,871   34,682   191  
Cost of Revenue -   -   -  
Gross Profit 64,871   34,682   191  
Operating Expenses
Research Development57,899  35,670  28,828  
Selling General and Administrative25,314  15,054  10,000  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (18,342) (16,043) (38,637)
Income from Continuing Operations
Total Other Income/Expenses Net312  (620)93  
Earnings Before Interest And Taxes(18,030)(16,663)(38,544)
Interest Expense2  629  1,988  
Income Before Tax(18,032)(17,292)(40,532)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(18,032)(17,292)(40,532)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (18,032) (17,292) (40,532)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (18,032) (17,292) (40,532)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.